Health
COVID-19 Scandal Prompts Change in Review Process – Pulitzer Center on Crisis Reporting
Three months after retracting a high-profile COVID-19 paper, editors at The Lancet hope to assure the research community that they’ve learned their lesson.
Three months after retracting a high-profile COVID-19 paper, editors at The Lancet hope to assure the research community that theyve learned their lesson. The journal yanked a study on the risks of hydroxychloroquinean antimalarial drug whose proposed use as a COVID-19 treatment has stirred scientific and political controversyin June when its authors couldnt prove the underlying patient data even existed. It has announced policies, effective immediately, that aim to keep flawed studies using lar…
Continue Reading